...
首页> 外文期刊>Journal of nanoparticle research: An interdisciplinary forum for nanoscale science and technology >Facile, productive, and cost-effective synthesis of a novel tetrazine-based iron oxide nanoparticle for targeted image contrast agents and nanomedicines
【24h】

Facile, productive, and cost-effective synthesis of a novel tetrazine-based iron oxide nanoparticle for targeted image contrast agents and nanomedicines

机译:适用于靶向图像造影剂和纳米海内西的新型四嗪基氧化铁纳米粒子的嵌合,生产和经济高效合成

获取原文
获取原文并翻译 | 示例

摘要

We have developed an operationally simple, time, and cost-effective protocol to produce a novel tetrazine-based iron oxide nanoparticle using commercially available and inexpensive materials. Our protocol proceeds at room temperature and uses hexafluorophosphate azabenzotriazole tetramethyl uronium, a well-known, widely used reagent for the large-scale industrial production of important pharmaceuticals. The nanoparticles obtained have a diameter range between 16 and 21 nm and showed no toxicity against endothelial cell lines. The tetrazine moiety on the nanoparticle surface could potentially allow further attachment of specific targeting vectors by using so-called copper-free click chemistry. We therefore anticipate that our protocol can represent a significant break-through in the future development and commercialization of improved, tissue-specific contrast agents and drug delivery for clinical diagnosis, monitoring and therapy of diseases at an asymptomatic stage.
机译:我们开发了一种操作简单,时间和经济高效的方案,以生产使用市售和廉价的材料生产新的四嗪基氧化铁纳米粒子。 我们的方案在室温下进行,并使用六氟磷酸氮苯并三唑四甲基铀,是一个众所周知的,广泛使用的试剂,用于重要的药物的大规模工业生产。 得到的纳米颗粒的直径范围为16至21nm,并且对内皮细胞系没有毒性。 纳米颗粒表面上的四嗪部分可以通过使用所谓的无铜咔哒化学来允许进一步附着特异的靶向载体。 因此,我们预计我们的协议可以在未来的开发和商业化方面代表改善,组织特异性造影剂和药物递送的显着突破,用于在无症状阶段的疾病的疾病进行疾病。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号